Navigation Links
FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis
Date:4/15/2011

SILVER SPRING, Md., April 15, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Actemra (tocilizumab), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in children ages 2 years and older.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

SJIA, or Still's disease, is a rare, potentially life-threatening disorder in children that causes severe inflammation throughout the body. SJIA is distinguished from other forms of juvenile idiopathic arthritis (JIA) by the prominence of systemic and inflammatory features, including spiking fevers; rash; swelling and inflammation of lymph nodes, liver, and spleen; and high white blood cell and platelet counts. The prevalence of JIA is an estimated 1 to 2 per 1,000 children, and SJIA affects about 10 percent of all JIA patients.

Actemra is an interleukin-6 receptor blocker approved by the FDA on Jan. 8, 2010, for treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to other approved therapies.

"This new indication of Actemra provides the first approved therapy for children with this rare disease," said Badrul Chowdhury, M.D., Ph.D., director of the Division of Pulmonary, Allergy, and Rheumatology Products in the FDA's Center for Drug Evaluation and Research.

An international, multicenter controlled trial demonstrated the safety and effectiveness of Actemra, in which 112 patients received either Actemra infusions or placebo infusions every two weeks. Study participants included patients with SJIA aged 2 to 17 years old who had inadequate response to or who were unable to take nonsteroidal anti-inflammatory drugs and corticosteroids.

Eighty-five percent of those receiving Actemra responded to treatment, compared with 24 percent of patients receiving pl
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves New Medical Device for Form of Brain Cancer
2. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
3. FDA Approves Horizant To Treat Restless Legs Syndrome
4. FDA Approves New Treatment for Rare Form of Thyroid Cancer
5. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
6. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
7. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
8. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
9. FDA Approves Gadavist for Central Nervous System Scans
10. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
11. FDA Approves Device to Maintain Blood Flow During Artery Bypass Brain Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... ALBANY, N.Y. , Oct. 20, 2014 ... pharmaceutical outsourcing facility in Albany, NY ... and trials. The company meets and/or exceeds the FDA ... 210 and 21 CFR Part 211. ... provide the highest levels of quality assurance and quality ...
(Date:10/19/2014)... -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) ... 2014 financial results on Wednesday, October 29, 2014, after ... announcement, members of the management team will host a ... a general corporate update at 4:30 p.m. EDT (1:30 ... as follows: Wednesday, October 29 1:30 ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
Breaking Medicine Technology:CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... , MINNETONKA, Minn., Dec. 1 ... company specializing in clinical study management systems, today ... technology solution, has been certified by the Clinical ... the Operational Data Model (ODM) standard. This ...
... , CAMBRIDGE, Mass. and TOKYO, Dec. 1 Galenea ... further extension of their research and development collaboration through ... to seven years and brings the total committed funding ... working together since January 2005 with the goal of ...
Cached Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3
(Date:10/20/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Sit and Slim ... 10 not to purchase or use Sit and Slim II ... Slim II is promoted as weight loss product on various ... from the market in 2010 for safety reasons, can significantly ...
(Date:10/20/2014)... Rockynol Retirement Community broke ... 14. The $11 million project will include the latest ... kitchen with full-service restaurant style dining. , “We are ... class Assisted Living apartments,” said Kara Hanzie, Rockynol Executive ... quality of care and this investment is proof of ...
(Date:10/20/2014)... Fort Collins, CO (PRWEB) October 20, 2014 ... platform, dGH assays are the only imaging assays ... data in a single test.  With these three ... in their ability to detect the widest range ... chromosomal translocations—mutations usually missed by other genomic tools, ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from Pixel Film ... FCPX filmmakers . , “Fun, cool, and simple are ... Says Christina Austin, CEO of Pixel Film Studios. “It has ... comes with all the tools needed for a full ... added style, a title screen for an introduction, two lower ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2
... the 12 Million Americans With Food Allergy, FAIRFAX, ... (FAAN) will sponsor an educational briefing on Capitol,Hill to ... honor of,the 11th annual Food Allergy Awareness Week, May ... the challenges of food allergy,through five steps aimed at ...
... Va., May 8 Pending cuts to the,Medicare ... of,physical therapists to serve the rehabilitation needs of ... costs while decreasing quality of,care, according to the ... Section., In testimony May 8 before a ...
... gruesome,discovery of aborted babies in a dumpster behind Dr. ... a Pro-Life Society,discovered the mutilated bodies of aborted babies ... owned by Dr. Reginald Sharpe., "It is indeed ... that we,must stop and take time to grieve the ...
... Tenn., May 8 TeamHealth Inc.,s parent,company, Team ... the,first quarter ended March 31, 2008., The ... anesthesia,management services business line and substantially completed the ... of 2007. As a result, in,accordance with relevant ...
... Care Conference on May 13 - ... on May 14 -, SAN DIEGO, May 8 Gen-Probe Incorporated,(Nasdaq: ... Bank of,America 2008 Health Care Conference in Las Vegas on May 13, ... the Baird,Growth Stock Conference in Chicago on May 14, 2008 at approximately ...
... increased odds of heart attack, death, study finds , , THURSDAY, ... doctor can hear when passing a stethoscope over a main ... heart attack and death from heart disease and stroke, a ... bruit (pronounced brew-ee) -- is caused by turbulent blood flow ...
Cached Medicine News:Health News:Five Steps Forward for Food Allergy 2Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 2Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 3Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 4Health News:ALL: More Dead Babies Found in Michigan Dumpsters 2Health News:Team Finance LLC Announces First Quarter 2008 Results 2Health News:Team Finance LLC Announces First Quarter 2008 Results 3Health News:Team Finance LLC Announces First Quarter 2008 Results 4Health News:Team Finance LLC Announces First Quarter 2008 Results 5Health News:Team Finance LLC Announces First Quarter 2008 Results 6Health News:Team Finance LLC Announces First Quarter 2008 Results 7Health News:Gen-Probe to Webcast Two Upcoming Investor Presentations 2Health News:Noise in Artery Could Warn of Heart Risk 2
... Re-insulation capabilities that extend the life ... that bring them back to life, expertise ... Instrument trademark. Our maintenance capabilities always help ... , Economical and fast, not only do ...
Inquire...
... your camera upon arrival.,Our technician then makes note ... with a thorough customer quote. We respect that ... so well help you prioritize repairs. With customer ... , ISI uses only OEM or widely approved ...
... an ISI technician carefully inspects your ... and all problems, and provides you ... respect that you may be working ... help you prioritize repairs. With customer ...
Medicine Products: